Latest Insider Transactions at Clene Inc. (CLNN)
This section provides a real-time view of insider transactions for Clene Inc. (CLNN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Clene Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Clene Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2021
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
20,000
+1.39%
|
$100,000
$5.26 P/Share
|
|
Nov 15
2021
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
15,000
+1.06%
|
$75,000
$5.71 P/Share
|
|
Nov 12
2021
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.71%
|
$50,000
$5.37 P/Share
|
|
Oct 01
2021
|
Alison Mosca Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
25,000
+0.59%
|
$0
$0.01 P/Share
|
|
Jul 14
2021
|
John Henry Stevens |
BUY
Grant, award, or other acquisition
|
Direct |
14,378
+50.0%
|
-
|
|
Jul 14
2021
|
Alison Mosca Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+50.0%
|
-
|
|
Jul 14
2021
|
Shalom Jacobovitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,838
+50.0%
|
-
|
|
Jul 14
2021
|
Jonathon Gay Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,783
+50.0%
|
-
|
|
Jul 14
2021
|
Reed N Wilcox Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,784
+50.0%
|
-
|
|
Jun 30
2021
|
Robert Dee Etherington President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,076
+50.0%
|
-
|
|
Jun 30
2021
|
Mark Mortenson Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,082
+50.0%
|
-
|
|
Jun 30
2021
|
Robert Glanzman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,281
+50.0%
|
-
|
|
May 24
2021
|
David J Matlin Director |
BUY
Open market or private purchase
|
Direct |
207,684
+13.09%
|
$1,869,156
$9.63 P/Share
|
|
May 24
2021
|
Alison Mosca Director |
BUY
Open market or private purchase
|
Indirect |
51,921
+50.0%
|
$467,289
$9.63 P/Share
|